Dr. Reddy’s sets Q2FY27 earnings for October 23, 2026

Management will discuss financial performance on a scheduled call, with audio and a transcript to be posted on the company’s website.

Rhea-AI Filing Summary

DR. REDDY’S LABORATORIES LIMITED will announce results for the quarter and six months ended September 30, 2026, on Friday, October 23, 2026, after the Board Meeting. The company will host an earnings call that day at 19:30 PM IST / 10:00 AM ET to discuss its financial performance. The press-meet presentation, and the call’s audio and transcript, will be available on the company’s website.

Key Figures

Results announcement: October 23, 2026 Reporting period end: September 30, 2026 Earnings call time: 19:30 PM IST / 10:00 AM ET

3 metrics

Results announcement October 23, 2026 Results for the quarter and six months ended September 30, 2026

Reporting period end September 30, 2026 Quarter and six months

Earnings call time 19:30 PM IST / 10:00 AM ET Friday, October 23, 2026

Key Terms

Q2FY27, FOREIGN PRIVATE ISSUER, Form 20-F

3 terms

Q2FY27 financial

"release Q2FY27 results"

FOREIGN PRIVATE ISSUER regulatory

"REPORT OF FOREIGN PRIVATE ISSUER"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Form 20-F regulatory

"Form 20-F x Form 40-F"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will RDY report Q2FY27 results?

DR. REDDY’S LABORATORIES LIMITED will announce results for the quarter and six months ended September 30, 2026, on Friday, October 23, 2026, after the Board Meeting.

What time is the RDY Q2FY27 earnings call?

The company’s earnings call is scheduled for 19:30 PM IST / 10:00 AM ET on Friday, October 23, 2026. The company says the call’s audio and transcript will be available on its website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/07/2026 - 06:56 AM Accepted by SEC EDGAR 10/07/2026 - 06:55 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

October, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                              Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                               No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated October 07, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: October 07, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:       + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

October 07, 2026

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)

BSE Limited (Stock Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/ Madam,

Sub: Intimation of Earnings call

Please find enclosed a notification titled “Dr. Reddy's to release Q2FY27 results on Friday, October 23^rd, 2026; Earnings call slated @19:30 PM IST / 10:00 AM ET.”

This is for your information and records.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

	CONTACT
DR. REDDY'S LABORATORIES LTD.	Investor relationS	Media relationS
8-2-337, Road No. 3, Banjara Hills,	Aishwarya sitharam	SANTOSH VYAS
Hyderabad – 500034, Telangana, India.	aishwaryasitharam@drreddys.com	santoshvyas@drreddys.com

Dr. Reddy's to release Q2FY27 results on Friday, October 23^rd, 2026;

Earnings call slated @19:30 PM IST / 10:00 AM ET

Hyderabad, India, October 7^th, 2026

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the quarter and six months ended September 30^th, 2026 on Friday, October 23^rd, 2026 after the Board Meeting.

Summary of Events

Event	Date and Time	Medium
Release of financial results	Friday, October 23rd, 2026, after the Board Meeting	Stock Exchange, Media, Company Website, Email
Press Meet Presentation	Will be available on the Company’s Website	Stock Exchange, Company’s Website www.drreddys.com
Earnings Call	Friday, October 23rd, 2026 at 19:30 PM IST / 10:00 AM ET	Hosted by the Company (Details below)
Audio as well as Transcript of the Earnings call	Will be available on the Company’s Website	Stock Exchange, Company’s Website www.drreddys.com

Earnings Call

Following the release, the management of the Company will host its earnings call to discuss the Company’s financial performance.

Pre-register with the link below:

https://drreddys.zoom.us/webinar/register/WN_fADmy9O6Tbqdycq7Ed8YOA

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 49.2 KB